Search the Newsreel

Earnings call transcript: IRadimed tops Q2 2026 estimates as 3870 ramp weighs margins

IRadimed anticipates Q3 revenue of $23M-$24.5M as 3870 pump production ramps to over 300 units

Earnings Call Insights: IRadimed (IRMD) Q2 2026 MANAGEMENT VIEW * “This quarter, we embarked on the first general release production of the new 3870 MR IV pump system as planned, targeting... the building of 130 to 135 of these new pumps,” and “achieved our …

IRADIMED: More Than 70% of New Pump Orders Were Four-Pump Setups

IRADIMED (NASDAQ: IRMD) announced its Q2 2026 financial results, reporting $20.5 million in revenue, up 0.5% year-over-year, with GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46. The company reaffirmed its full-year 2026 guidance, expecting $91.0–$96.0 million in revenue and GAAP EPS …

IRadimed: Q2 Earnings Snapshot

This article provides a Q2 earnings snapshot for IRadimed. The content is concise and directly presents the company's performance for the quarter.

Iradimed reports Q2 revenue $20.5M, EPS $0.41; raises dividend to $0.20 and reaffirms 2026 guidance

Iradimed (IRMD) reported Q2 revenue of $20.5 million and diluted EPS of $0.41, alongside declaring a $0.20 quarterly dividend. The company reaffirmed its Q3 and full-year 2026 revenue and GAAP EPS guidance, anticipating revenue between $91.0M–$96.0M and GAAP EPS of $1.90–$2.05 for the full …

Enterprise value to EBITDA forward of Khadim India Limited – NSE:KHADIM

iRadimed (NASDAQ:IRMD) Releases Q3 2026 Earnings Guidance

Iradimed Co earnings beat by $0.02, revenue topped estimates

Renaissance Technologies LLC Sells 15,700 Shares of iRadimed Corporation $IRMD

Renaissance Technologies LLC reduced its stake in iRadimed Corporation by 3.4% during the first quarter, selling 15,700 shares but still retaining 440,712 shares valued at approximately $42.4 million. Despite this sale, institutional investors collectively own 92.34% of the company, and analysts maintain a "Buy" …

DIMAND SOCIETE ANONYME DEVELOPMENT & EXPLOITATION OF REAL ESTATE & CONSTRUCTIONS SERVICES & HOLDING Revenue Breakdown – ATHEX:DIMAND

Form 144 Dime Community Bancshares For: 30 July By Investing.com

This article announces the filing of Form 144 for Dime Community Bancshares on July 30. It provides a brief update on insider trading for the company. The content primarily serves as a notice, embedding the information within a larger financial news portal.

Iradimed earnings on deck as growth momentum faces Q2 test

Iradimed (IRMD) is set to report its second-quarter earnings, with analysts expecting $0.44 earnings per share on $20.35 million in revenue, a sequential decline from Q1. Investors will focus on the performance of its new MRI-compatible IV infusion pump, margin sustainability, and management's reaffirmation …

5 Revealing Analyst Questions From Dime Community Bancshares’s Q2 Earnings Call

What Is Bringing Dimerix (ASX:DXB) Back Into Focus?

Nano Dimension Ltd (NNDM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nano Dimension Ltd (NNDM), focusing on its stock price momentum, support and resistance levels, and various technical indicators. It notes that NNDM's stock price currently trades between a resistance level of $1.61 and a support level of …

Nano Dimension Ltd (NNDM) Institutional Confidence

This article details the institutional confidence score for Nano Dimension Ltd (NNDM), which currently stands at 3.00, ranking 37 out of 60 in its industry. The institutional shareholding proportion is 33.83%, showing a slight quarter-over-quarter decrease. Key institutional shareholders and changes in their holdings …

Record Results, New MRI Pump And Dividend Hike Might Change The Case For Investing In IRADIMED (IRMD)

IRADIMED (IRMD) recently reported record 2025 results, strong Q1 2026, and FDA clearance for its upgraded MRidium 3870 MRI IV infusion pump, alongside an increased quarterly dividend. These developments, particularly the new pump expected to drive replacement demand, are highlighted as potentially reshaping the …

Nano Dimension Number of Employees 2026 | Employee Count & Headcount Data

Nano Dimension Ltd. (NNDM) had approximately 475 employees worldwide as of March 2026, marking a 37.1% decline from 2023. Despite this, the company is actively hiring, with 44 active job postings in 2026, a 14.6% increase from 2025. The workforce is concentrated in the …

Is Dime Commercial Bancshares (DCOM) Undervalued As Q2 Earnings Beat And Buybacks Return?

ImpediMed (ASX:IPD) Raises Capital to Fund SOZO Platform Growth

IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of IRadimed Corp (IRMD), noting its current financial score is 9.60, ranking it 2nd in the Healthcare Equipment & Supplies industry. It highlights the company's robust financial status and high operating efficiency, with a recent quarterly revenue …

BlackRock (IRMD holder) discloses 5.01% IRADIMED CORP stake on Schedule 13G

BlackRock, Inc. has disclosed a passive ownership stake of 5.01% in IRADIMED CORP (IRMD) common stock, as reported on a Schedule 13G filing. As of June 30, 2026, BlackRock beneficially owned 641,128 shares, with sole voting power over 622,925 shares and sole dispositive power …

Tang Capital group (NNDM) discloses 16.7M-share Nano Dimension position

Tang Capital Management and affiliated entities have filed an amended Schedule 13D, revealing beneficial ownership of 16,715,812 ordinary shares in Nano Dimension Ltd. (NNDM), which represents 7.9% of the company's outstanding shares. Since June 30, 2026, the group has invested approximately $3.6 million to …

Form 13D/A Nano Dimension Ltd. For: 27 July By Investing.com

This article announces the filing of Form 13D/A by Nano Dimension Ltd. for July 27th. The brief piece primarily serves as a notification regarding this SEC filing, providing no further details about the content of the form. It indicates that more information can be …

Nano Dimension (NASDAQ:NNDM) Stock Passes Below 50-Day Moving Average - Here's Why

Nano Dimension (NASDAQ:NNDM) stock recently fell below its 50-day moving average, trading as low as $1.4601 and closing at $1.48, compared to an average of $1.51. The company faces strongly negative analyst sentiment, with several "sell" ratings. Despite institutional investors owning 33.89% of the …

Dimerix (ASX:DXB) Expands Kidney Pipeline With DMX-652 Acquisition and Long-Dated Patent Protection

NNDM|Nano Dimension Ltd|Price:1.480|Chg%:+0.010

TradingKey provides a comprehensive stock analysis of Nano Dimension Ltd (NNDM), highlighting its strong fundamentals, high growth potential with revenue averaging 81.90% year-on-year, and a net income of USD 102.44M. Despite a "fairly valued" assessment and a sideways trading pattern, institutional ownership is very …

Nano Dimension Ltd (NNDM) Cash Flow

This article provides a detailed historical cash flow statement for Nano Dimension Ltd (NNDM), covering quarterly and annual data from FY2012Q1 to FY2026Q1 across operating, investing, and financing activities. It presents key financial metrics such as net income from continuing operations, capital expenditures, and …

Nano Dimension’s $890 Million AI Healthcare Pivot Now Hangs in the Balance

Nano Dimension, a former 3D printer manufacturer, signed a non-binding term sheet to merge with Infinite Epigenetics, an AI-powered preventive health company, in an $890 million deal signaling a full pivot to healthcare AI. The transaction, meant to exit the additive manufacturing sector, is …

Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline

Riverwater Partners, an investment management company, released its "Micro Opportunities Strategy" Q2 2026 investor letter. A copy of the letter is available to download here. In Q2 2026, the Micro Opportunities strategy underperformed the Russell Microcap Index, despite a positive absolute result. The benchmark …

Nano Dimension Ltd (NNDM) Income Statement

IRMD|IRadimed Corp|Price:94.860|Chg%:+0.370

This article provides a comprehensive stock analysis of IRadimed Corp (IRMD) by TradingKey, highlighting its strong fundamentals, high growth potential, and institutional confidence. The company specializes in MRI-compatible medical devices, with revenue growth averaging 27.84% annually over the last three years and high dividend …

Can IradiMed Extend Its Earnings Momentum In Q2 2026, Will Device Sales Continue To Climb?

(RTTNews) - IRADIMED CORPORATION (IRMD), a medical device company, announced Friday that it will release its results for the second quarter of fiscal 2026 before the market opens on July 31, 2026. The company's management will host a conference call at 11:00 a.m. ET …

Dime Community Bancshares Inc (DCOM) Institutional Confidence

IRadimed Corp (IRMD) Stock Price Live, Chart & News - TradingKey

IRadimed Corp (IRMD) is currently trading at $92.495, up 1.41%. The company specializes in MRI-compatible medical devices, including IV infusion pumps and vital signs monitors. Analysts rate IRMD as a "Buy" with a target price of $118.00, indicating a 29.37% upside.

IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for IRadimed Corp (IRMD), segmenting its revenue by business and by region. The data, updated on April 6, analyzes contributions from MRI-compatible IV infusion pumps, patient vital signs monitoring systems, disposables, extended warranty amortization, and ferro magnetic …